Business
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference PR News...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference\n\n\nBausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n\n\n\n\n\nPR Newswire\n\n\nLAVAL, QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 14, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.\nJean-Jacques (JJ) Charhon, EVP, Chief Financial Officer, and Jonathan Sadeh, M.D., EVP, Chief Medical Officer and Head of R&D will also be in attendance.\nDetails\nDate: Wednesday, January 14, 2026\nTime: 3:45 p.m. U.S. PT / 6:45 p.m. U.S. ET\nWebcast: http://ir.bauschhealth.com/events-and-presentations\nA replay of the event will be available on the investor relations website following the event.\nAbout Bausch Health Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.\nForward-looking Statements This news release may contain forward-looking statements wi...